R
Richard A. Cash
Researcher at Harvard University
Publications - 81
Citations - 3024
Richard A. Cash is an academic researcher from Harvard University. The author has contributed to research in topics: Cholera & Population. The author has an hindex of 26, co-authored 80 publications receiving 2885 citations. Previous affiliations of Richard A. Cash include Johns Hopkins University & SUNY Downstate Medical Center.
Papers
More filters
Journal ArticleDOI
Response of man to infection with Vibrio cholerae. I. Clinical, serologic, and bacteriologic responses to a known inoculum.
Richard A. Cash,S. I. Music,Joseph P. Libonati,Merrill J. Snyder,Richard P. Wenzel,Richard B. Hornick +5 more
TL;DR: The spectrum of illness and the immunologic response produced by cholera in volunteers were studied and Titers of vibriocidal antibody rose after diarrhea, peaked the second week after challenge, and rapidly fell during the next four weeks.
Journal ArticleDOI
Treatment of diarrhoea in Indonesian children: what it costs and who pays for it.
TL;DR: The annual economic burden of diarrhoea in four subdistricts in Indonesia averaged $2.27 per child aged under 5 years when health centre, hospital, and private expenditures were all considered, and medication costs were for antimicrobial agents and iodochlorhydroxyquin in the private sector.
Journal ArticleDOI
Has COVID-19 subverted global health?
Richard A. Cash,Vikram Patel +1 more
TL;DR: It is argued that these strategies might subvert two core principles of global health: that context matters and that social justice and equity are paramount and question the appropriateness of these particular strategies for less-resourced countries with distinct population structures, vastly different public health needs, immensely fewer health-care resources, less participatory governance, massive within-country inequities, and fragile economies.
Journal ArticleDOI
Oral maintenance therapy for cholera in adults.
TL;DR: An oral solution containing glucose, sodium chloride, sodium bicarbonate, and potassium chloride or citrate was used as maintenance therapy for acute cholera, and patients who received the oral solution required 80% less intravenous fluids for cure.
Journal ArticleDOI
Response of Man to Infection with Vibrio cholerae. II. Protection from Illness Afforded by Previous Disease and Vaccine
Richard A. Cash,Richard A. Cash,S. I. Music,S. I. Music,S. I. Music,J. P. Libonati,J. P. Libonati,John P. Craig,John P. Craig,Nathaniel F. Pierce,R. B. Hornick,R. B. Hornick +11 more
TL;DR: In this article, the authors evaluated human immunity acquired after cholera or provided by choline vaccines and found that immunity, either naturally acquired or vaccine-induced, appeared to be directed against the vibrio rather than against the toxin.